Cargando…

Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner

Alterations in ERBB family members have been associated with many tumor malignancies. EGFR and ERBB2 have been extensively explored in clinical oncology and several drugs currently target them therapeutically. However, the significance of ERBB4 as a potential therapeutic target remains mostly unexpl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauf, Femina, Festa, Fernanda, Park, Jin G., Magee, Mitchell, Eaton, Seron, Rinaldi, Capria, Betanzos, Carlos Morales, Gonzalez-Malerva, Laura, LaBaer, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916919/ https://www.ncbi.nlm.nih.gov/pubmed/29398709 http://dx.doi.org/10.1038/s41388-017-0079-x

Ejemplares similares

In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance
por: Wang, Wei, et al.
Publicado: (2014)

Measurement of Small Molecule Binding Kinetics on a Protein Microarray by Plasmonic-Based Electrochemical Impedance Imaging
por: Liang, Wenbin, et al.
Publicado: (2014)

Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants
por: Pal, Anasuya, et al.
Publicado: (2023)

Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner
por: Liu, Jia, et al.
Publicado: (2022)

Microreactor Array Device
por: Wiktor, Peter, et al.
Publicado: (2015)

Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001)

A Quantitative Systems Approach to Define Novel Effects of Tumour p53 Mutations on Binding Oncoprotein MDM2
por: Fuentes, Manuel, et al.
Publicado: (2021)

Galvanismo /
por: Malerva Morales, María Elena
Publicado: (2005)

Multi-platform Approach for Microbial Biomarker Identification Using Borrelia burgdorferi as a Model
por: Pflughoeft, Kathryn J., et al.
Publicado: (2019)

Vibrio cholerae Proteome-Wide Screen for Immunostimulatory Proteins Identifies Phosphatidylserine Decarboxylase as a Novel Toll-Like Receptor 4 Agonist
por: Thanawastien, Ann, et al.
Publicado: (2009)

Serum autoantibodyome reveals that healthy individuals share common autoantibodies.
por: Shome, Mahasish, et al.
Publicado: (2022)

Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019)

Extrahepatic metabolism of ibrutinib
por: Rood, Johannes J. M., et al.
Publicado: (2020)

Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
por: Bu, Wen, et al.
Publicado: (2013)

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
por: Yu, J, et al.
Publicado: (2017)

A systematic approach for testing expression of human full-length proteins in cell-free expression systems
por: Langlais, Claudia, et al.
Publicado: (2007)

A Functional Genomic Yeast Screen to Identify Pathogenic Bacterial Proteins
por: Slagowski, Naomi L, et al.
Publicado: (2008)

Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays
por: Gibson, David S, et al.
Publicado: (2012)

AAgAtlas 1.0: a human autoantigen database
por: Wang, Dan, et al.
Publicado: (2017)

Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Publicado: (2021)

A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib
por: Karvaly, Gellért Balázs, et al.
Publicado: (2022)

A novel approach to sequence validating protein expression clones with automated decision making
por: Taycher, Elena, et al.
Publicado: (2007)

Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma
por: Yu, Jian, et al.
Publicado: (2018)

Ibrutinib for B cell malignancies
por: Novero, Aileen, et al.
Publicado: (2014)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Ibrutinib: Pneumonitis: case report
Publicado: (2021)

Arrhythmia Patterns in Patients on Ibrutinib
por: Fazal, Muhammad, et al.
Publicado: (2022)

Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children’s Oncology Group
por: Hingorani, Pooja, et al.
Publicado: (2020)

Construction of gateway-compatible baculovirus expression vectors for high-throughput protein expression and in vivo microcrystal screening
por: Tang, Yanyang, et al.
Publicado: (2020)

Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner
por: Grigson, Eileen R., et al.
Publicado: (2015)

PlasmID: a centralized repository for plasmid clone information and distribution
por: Zuo, Dongmei, et al.
Publicado: (2007)

Ibrutinib as a potential therapeutic for cocaine use disorder
por: Huggett, Spencer B., et al.
Publicado: (2021)

Profound Sinoatrial Arrest Associated with Ibrutinib
por: Mathur, Kanupriya, et al.
Publicado: (2017)

Ibrutinib‐induced severe liver injury
por: Nandikolla, Amara G., et al.
Publicado: (2017)

Electrocardiographic Changes Associated With Ibrutinib Exposure
por: Fradley, Michael G., et al.
Publicado: (2020)

Ibrutinib dose modifications in the management of CLL
por: Hardy-Abeloos, Camille, et al.
Publicado: (2020)

Invasive Aspergillosis in Patients Treated With Ibrutinib
por: Fürstenau, Moritz, et al.
Publicado: (2020)

Cystoid macular edema secondary to ibrutinib
por: Ben-Avi, Ravid, et al.
Publicado: (2022)

Death from diltiazem–ibrutinib interaction
por: Falconer, Nazanin, et al.
Publicado: (2021)

PORCN promotes hepatocellular carcinogenesis via Wnt/β-catenin-dependent manner
por: Wu, Shuzhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7aecqvlm85fqtkrms6j3e2dmls